50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,642.79 (-0.34%)
DOW   29,130.46 (-0.45%)
QQQ   273.05 (-0.48%)
AAPL   150.92 (+0.10%)
MSFT   234.95 (-1.05%)
META   135.16 (-0.89%)
GOOGL   96.99 (-1.20%)
AMZN   113.65 (-1.30%)
TSLA   279.21 (+1.16%)
NVDA   122.94 (+0.54%)
NIO   17.16 (-2.61%)
BABA   77.46 (-1.84%)
AMD   66.22 (-0.12%)
T   15.77 (+0.64%)
MU   49.75 (+1.78%)
CGC   2.77 (+1.09%)
F   11.74 (-2.09%)
GE   63.78 (-0.89%)
DIS   96.54 (-1.61%)
AMC   7.05 (+3.22%)
PYPL   84.95 (+0.82%)
PFE   43.87 (+0.09%)
NFLX   222.70 (-0.61%)
S&P 500   3,642.79 (-0.34%)
DOW   29,130.46 (-0.45%)
QQQ   273.05 (-0.48%)
AAPL   150.92 (+0.10%)
MSFT   234.95 (-1.05%)
META   135.16 (-0.89%)
GOOGL   96.99 (-1.20%)
AMZN   113.65 (-1.30%)
TSLA   279.21 (+1.16%)
NVDA   122.94 (+0.54%)
NIO   17.16 (-2.61%)
BABA   77.46 (-1.84%)
AMD   66.22 (-0.12%)
T   15.77 (+0.64%)
MU   49.75 (+1.78%)
CGC   2.77 (+1.09%)
F   11.74 (-2.09%)
GE   63.78 (-0.89%)
DIS   96.54 (-1.61%)
AMC   7.05 (+3.22%)
PYPL   84.95 (+0.82%)
PFE   43.87 (+0.09%)
NFLX   222.70 (-0.61%)
S&P 500   3,642.79 (-0.34%)
DOW   29,130.46 (-0.45%)
QQQ   273.05 (-0.48%)
AAPL   150.92 (+0.10%)
MSFT   234.95 (-1.05%)
META   135.16 (-0.89%)
GOOGL   96.99 (-1.20%)
AMZN   113.65 (-1.30%)
TSLA   279.21 (+1.16%)
NVDA   122.94 (+0.54%)
NIO   17.16 (-2.61%)
BABA   77.46 (-1.84%)
AMD   66.22 (-0.12%)
T   15.77 (+0.64%)
MU   49.75 (+1.78%)
CGC   2.77 (+1.09%)
F   11.74 (-2.09%)
GE   63.78 (-0.89%)
DIS   96.54 (-1.61%)
AMC   7.05 (+3.22%)
PYPL   84.95 (+0.82%)
PFE   43.87 (+0.09%)
NFLX   222.70 (-0.61%)
S&P 500   3,642.79 (-0.34%)
DOW   29,130.46 (-0.45%)
QQQ   273.05 (-0.48%)
AAPL   150.92 (+0.10%)
MSFT   234.95 (-1.05%)
META   135.16 (-0.89%)
GOOGL   96.99 (-1.20%)
AMZN   113.65 (-1.30%)
TSLA   279.21 (+1.16%)
NVDA   122.94 (+0.54%)
NIO   17.16 (-2.61%)
BABA   77.46 (-1.84%)
AMD   66.22 (-0.12%)
T   15.77 (+0.64%)
MU   49.75 (+1.78%)
CGC   2.77 (+1.09%)
F   11.74 (-2.09%)
GE   63.78 (-0.89%)
DIS   96.54 (-1.61%)
AMC   7.05 (+3.22%)
PYPL   84.95 (+0.82%)
PFE   43.87 (+0.09%)
NFLX   222.70 (-0.61%)
OTCMKTS:BTCY

Biotricity - BTCY Stock Forecast, Price & News

$0.85
-0.08 (-8.85%)
(As of 09/26/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.80
$0.93
50-Day Range
$0.85
$1.49
52-Week Range
$0.77
$5.30
Volume
36,502 shs
Average Volume
62,232 shs
Market Capitalization
$43.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.67

Biotricity MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
570.1% Upside
$5.67 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.33) to ($0.16) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.41 out of 5 stars

BTCY stock logo

About Biotricity (OTCMKTS:BTCY) Stock

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

BTCY Stock News Headlines

How High Can Copper Go?
To power the green revolution, copper demand continues to skyrocket with no end in sight. Prices hit a 10-year high; as copper jumped 79% in the past year. Some analysts are calling for copper to rise another 50-100%! We may be at the beginning of a copper bull run the likes we've never seen before. Just how high can copper go?
Waqaas Al-siddiq - Forbes
How High Can Copper Go?
To power the green revolution, copper demand continues to skyrocket with no end in sight. Prices hit a 10-year high; as copper jumped 79% in the past year. Some analysts are calling for copper to rise another 50-100%! We may be at the beginning of a copper bull run the likes we've never seen before. Just how high can copper go?
Biotricity to Join Russell Microcap(R) Index
Biotricity Issues Shareholder Update
See More Headlines
Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

BTCY Company Calendar

Last Earnings
7/14/2022
Today
9/27/2022
Next Earnings (Estimated)
11/02/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:BTCY
Fax
N/A
Employees
44
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.67
High Stock Price Forecast
$7.00
Low Stock Price Forecast
$4.00
Forecasted Upside/Downside
+570.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$-29,130,000.00
Net Margins
-360.56%
Pretax Margin
-380.78%

Debt

Sales & Book Value

Annual Sales
$7.70 million
Book Value
($0.04) per share

Miscellaneous

Free Float
N/A
Market Cap
$43.89 million
Optionable
Not Optionable
Beta
1.69

Key Executives

  • Dr. Waqaas Al-Siddiq Ph.D. (Age 37)
    Founder, Pres, CEO & Chairman
    Comp: $717k
  • Mr. S. John Ayanoglou (Age 56)
    Chief Financial Officer
    Comp: $387k
  • Dr. George N. Nikopoulos
    Director of Bus. Devel.
  • Mr. Amir Ali
    Chief Devel. Officer













BTCY Stock - Frequently Asked Questions

Should I buy or sell Biotricity stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Biotricity in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" BTCY shares.
View BTCY analyst ratings
or view top-rated stocks.

What is Biotricity's stock price forecast for 2022?

3 brokers have issued 1 year price targets for Biotricity's stock. Their BTCY share price forecasts range from $4.00 to $7.00. On average, they predict the company's stock price to reach $5.67 in the next year. This suggests a possible upside of 570.1% from the stock's current price.
View analysts price targets for BTCY
or view top-rated stocks among Wall Street analysts.

How have BTCY shares performed in 2022?

Biotricity's stock was trading at $3.98 at the start of the year. Since then, BTCY stock has decreased by 78.8% and is now trading at $0.8457.
View the best growth stocks for 2022 here
.

When is Biotricity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our BTCY earnings forecast
.

How were Biotricity's earnings last quarter?

Biotricity, Inc. (OTCMKTS:BTCY) released its quarterly earnings results on Thursday, July, 14th. The company reported ($0.12) EPS for the quarter. The firm had revenue of $2.15 million for the quarter.

What other stocks do shareholders of Biotricity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Biotricity investors own include Axsome Therapeutics (AXSM), Bank of America (BAC), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Broadcom (AVGO), Cannabix Technologies (BLOZF), BioLineRx (BLRX), CV Sciences (CVSI) and Charlotte's Web (CWBHF).

What is Biotricity's stock symbol?

Biotricity trades on the OTCMKTS under the ticker symbol "BTCY."

Who are Biotricity's major shareholders?

Biotricity's stock is owned by a number of retail and institutional investors. Top institutional investors include Signature Wealth Management Partners LLC (0.07%), Bouchey Financial Group Ltd (0.05%), Bouchey Financial Group Ltd (0.05%), Cedar Mountain Advisors LLC (0.03%), Concourse Financial Group Securities Inc. (0.00%) and Group One Trading L.P. (0.00%).
View institutional ownership trends
.

How do I buy shares of Biotricity?

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Biotricity's stock price today?

One share of BTCY stock can currently be purchased for approximately $0.85.

How much money does Biotricity make?

Biotricity (OTCMKTS:BTCY) has a market capitalization of $43.89 million and generates $7.70 million in revenue each year. The company earns $-29,130,000.00 in net income (profit) each year or ($0.63) on an earnings per share basis.

How can I contact Biotricity?

The official website for the company is www.biotricity.com. The company can be reached via phone at (650) 832-1626.

This page (OTCMKTS:BTCY) was last updated on 9/27/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.